Standardized TAVR Protocol Improves Patient Outcomes

By

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

Following a standardized protocol during transcatheter aortic valve replacement (TAVR) can significantly improve outcomes, according to the global Optimize PRO study published in JSCAI.

Key Findings:

  • 600+ patients across 50 sites received Evolut PRO/PRO+ valves.
  • Sites using a four-step cusp overlap technique (COT) checklist saw lower rates of permanent pacemaker implantation (PPMI)—6.4% vs. 18.5% when not followed.
  • Standard protocol led to:
    • 0.8% mortality and 1.7% disabling stroke at 30 days.
    • 76% with no/trace aortic regurgitation.
    • Median 2-day hospital stay, with many eligible for next-day discharge.

Technique Matters:

  • Use of the Lunderquist guidewire halved PPMI rates (9% vs. 19%).
  • Sites with full adherence to protocol saw more reproducible, superior outcomes.

Expert Insight:
Dr. Hemal Gada highlighted the simplicity and global adaptability of the protocol: “Having a homogeneous, simple procedure with just a few steps improves patient outcomes.”

Follow MEDWIRE.AI for the latest in structural heart innovations.